Cornerstone Capital Group’s John Wilson will participate in this event.
A one-day interactive discussion and networking opportunity for senior biopharma Finance, Risk, and Sustainability officers to talk directly with financial market actors – analysts, portfolio managers, and asset managers – about sustainability performance and market value.
Gbola Amusa, Managing Director & Head of Healthcare Research at Chardan Capital Markets, will give the luncheon keynote, sharing an investor’s perspective on the value of sustainability in pharma and biotech. Workshop session leaders include:
For more details, visit the event registration page.
Read Cornerstone’s report from the 2014 Roundtable and Global Markets Strategist Michael Geraghty on BioPharma from an ESG perspective.